Figure 7.
Proliferation of breast cancer cells after repeated treatment with 250 μM pargyline, 2a and 2b. A. ERα-positive MCF7 cells. B. ERα-negative MDA-MB-231 cells.
Proliferation of breast cancer cells after repeated treatment with 250 μM pargyline, 2a and 2b. A. ERα-positive MCF7 cells. B. ERα-negative MDA-MB-231 cells.